当社グループは 3,000 以上の世界的なカンファレンスシリーズ 米国、ヨーロッパ、世界中で毎年イベントが開催されます。 1,000 のより科学的な学会からの支援を受けたアジア および 700 以上の オープン アクセスを発行ジャーナルには 50,000 人以上の著名人が掲載されており、科学者が編集委員として名高い

オープンアクセスジャーナルはより多くの読者と引用を獲得
700 ジャーナル 15,000,000 人の読者 各ジャーナルは 25,000 人以上の読者を獲得

抽象的な

Recurrence or Relapse of COVID 19 Infection

Gary R Skankey and Christopher Breeden

We report a patient, PCR positive for COVID 19, who developed respiratory failure and cytokine release syndrome, recovered after a prolonged period of mechanical ventilation, no longer require supplemental oxygen, and tested negative twice by COVID 19 PCR, relapsed within 40 days of initial infection. Laboratory findings, PO2 and chest radiograph findings were identical to the first episode, and COVID 19 PCR was again positive. Response was significantly better on remdesivir, now available, and the patient recovered with radiographic and respiratory recovery. Serum Covid 19 IgG drawn at the onset of the second episode was positive. This raised a few questions. First, was this a true relapse of infection? Second, if it was, does the IgG detected by the serum study, represent neutralizing antibody and be an indicator of immunity? Third, are there those who develop a weak, or incomplete immune response to the disease?